Oura to Acquire Counsel Health for $625 Million in Cash

Oura agreed on November 10, 2026, to acquire Counsel Health for $625 million in cash, subject to purchase-price adjustments, Counsel Health announced. The definitive agreement has not closed. Oura and Counsel Health expect to complete the transaction before the end of 2026, subject to customary closing conditions.

Under the announced agreement, Oura’s continuous biometric data would connect with Counsel’s medical AI and on-demand physicians, extending the smart-ring maker’s platform into primary care. The companies said the purchase would add a clinical workforce and enterprise care distribution to Oura’s biometric platform, while linking Counsel more closely to a continuous source of patient health data.

According to the companies, the market stakes are direct: Oura’s consumer wearable business would feed clinical decision-making, while Counsel Health’s medical-AI operation would gain a continuous-data channel. The arrangement joins continuous monitoring to software-supported guidance and physician-supervised care.

What does Counsel Health add to Oura?

Counsel Health said patients begin with an AI chat that can use connected medical records, previous interactions, evidence-based clinical guidelines and continuous biometric data to personalize guidance. The company places that chat inside a clinical AI harness.

The harness calls on specialized agents for:

• Medical history-taking
• Guideline retrieval
• Records review
• Emergency detection

Counsel Health said it evaluates each agent for performance, safety and quality, then improves the agents using feedback from its physicians. The stated development loop gives clinicians a direct role in the system that interprets records, retrieves guidelines and detects possible emergencies.

Patients can add a Counsel physician during a chat. When appropriate, that physician can provide a diagnosis, prescriptions and referrals, Counsel Health said. A patient can therefore move from automated guidance to clinical judgment within the same service.

When does the AI hand off to a physician?

Doctors work through a proprietary interface called the Clinician Cockpit. Counsel Health said the tool combines a patient’s medical record with longitudinal health trends to produce context-aware clinical suggestions. It serves as the clinical workspace behind the company’s on-demand physician offering.

Muthu Alagappan, Counsel Health’s founder and chief executive, said Oura’s data gives clinicians “objective context, trended biometrics, and member engagement to deliver more informed care.” His statement ties the ring data directly to the company’s clinical proposition.

An existing integration already lets Oura members move from an Oura health insight into a conversation with Counsel’s medical AI, Counsel Health said. If human care is needed, a board-certified Counsel physician can join within minutes. The interaction stays inside the Oura App, according to the announcement.

In practical terms, the combined service works like a clinician’s desk attached to a continuous sensor feed. Biometric trends inform the AI, connected records and clinical guidelines shape its guidance, and a physician can handle diagnosis, prescriptions and referrals when appropriate.

That sequence gives Oura a path from health tracking to active care delivery, according to the companies’ description. It also gives Counsel Health a route into the Oura App, where an insight can trigger a conversation without moving the member to a separate service.

What do early member figures show?

Oura and Counsel Health reported that more than 90% of surveyed Oura members using Counsel said their Oura data helped them obtain better care. Members who saw a Counsel physician rated the care experience 4.6 out of 5, the companies said.

The figures measure two parts of the proposition. The first reflects surveyed members’ view of whether Oura data improved their care. The second is a care-experience rating after a physician encounter. The companies presented both as evidence for the existing integration.

How far will the service expand?

The companies plan to extend their collaboration across preventive, acute, specialty and chronic care, Counsel Health said. Under that plan, continuous monitoring would support earlier recognition of possible health changes. The acute-care service would address episodic concerns with guidance, support or prescriptions.

Longer-running support would include reproductive health, aging and cardiometabolic health, according to the announcement. The proposed care spectrum would therefore extend beyond a one-time response to an insight, combining continuous monitoring with acute interventions and ongoing services.

Under the post-acquisition plan, Counsel Health said it would continue serving existing and new enterprise partners. The company named health plans, health systems, consumer health organizations and employers. This gives the combined service a distribution route beside Oura’s consumer app.

Oura executive chairman David Shuman said those enterprise relationships could extend the combined company’s reach to millions of people beyond Oura’s current members. He also said they could expand its addressable market, according to Counsel Health’s announcement.

The distribution strategy has two halves. Oura can bring members into a care workflow inside its app, while Counsel Health can continue distributing services to health plans, health systems, consumer health organizations and employers. The companies said that structure links consumer health data with enterprise care.

What is Oura’s financial position?

Oura reported preliminary, unaudited revenue of $533 million for the quarter ended September 30, 2026, a 153% year-over-year increase. The company released the figure alongside the acquisition agreement.

Oura also reported fiscal 2026 revenue of approximately $1.75 billion, up 92%. The company said it has more than six million members. Those figures place the $625 million purchase against a rapidly expanding member and revenue base.

Oura cautioned that the results remain preliminary and may change as it completes its year-end close and audit. The acquisition therefore lands before the company has published a final fiscal 2026 financial result.

The deal would add an operating clinical service to that growth, but the companies said it would also widen the scope of Oura’s data use. The wearable data would need to support timely care through an app and through Counsel Health’s enterprise channels, rather than remain confined to consumer health insights.

What has to work after the deal?

The practical test, according to the companies, is whether Oura can turn biometric insights into timely, physician-supervised care across both its app and Counsel Health’s enterprise channels. The second requirement is a clear handoff between AI guidance and clinical decisions.

The workflow spans software and service. The AI must interpret connected records, guidelines and biometric trends; the Clinician Cockpit must surface context-aware suggestions; physicians must be able to diagnose, prescribe and refer when appropriate; and the same care process must extend into Counsel Health’s enterprise channels.

The companies framed those links as the practical test for the acquisition. The next checkpoint is whether Oura and Counsel Health can move a member from a biometric insight to physician-supervised care without blurring the line between AI guidance and clinical decisions.